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EDITORIAL
A New Policy to Implement CONSORT Guidelines for
Surgical Randomized Controlled Trials
Pierre-Alain Clavien, MD, PhD,∗ and Keith D. Lillemoe, MD†
R igorously designed, conducted, and analyzed randomized controlled trials (RCTs) represent thegold standard in evaluating surgical interventions. If they are also reported completely and
transparently, this can lead to level 1 evidence.1 However, RCTs need methodological rigor and
complete reporting to be conclusive. To assess a trial accurately, readers of a published report need
sufficient, easily understandable, and transparent information on the methodology used. Knowledge
about the methodological accuracy and the relevant results of a trial can only be assessed if reporting
follows standardized methods. A systematic review of surgical RCTs published in this Journal
indicated that the study design was reported with sufficient detail in less than 40% of the articles.2
Although also incomplete in many studies, the quality of reporting seemed better for pharmacological
trials than for surgical trials.3
The need for guidelines was recognized in the early 1990s to overcome these shortcomings,
which led to the development of the original CONSORT (Consolidated Standards of Reporting Trials)
Statement in 1996,4 followed by 2 revisions, most recently in 2010.5,6 Although the implementation
of CONSORT guidelines undoubtedly improved the reporting quality for many RCTs, other reports,
including most surgical trials, remained grossly inadequate.6 Although CONSORT guidelines are
aimed at any types of RCTs, the focus was on the most common design type, that is, randomized,
2-group, and parallel trials.6 A further development, relevant for the surgical field, was the initiation
of the CONSORT extension targeting nonpharmacological trials (NPTs) covering a wide range of
interventions including surgical procedures or other interventions such as angioplasty or implantable
and nonimplantable medical devices.6,7 The CONSORT NPT statement takes into consideration
specific issueswhen assessing a variety of interventions, such as difficulties of blinding, the complexity
of the intervention, the influence of care providers’ expertise, the volume of case at participating
centers, and other factors affecting the treatment effects. For example, the CONSORT flow diagram
was modified to include data on the number of care providers and centers in each group and the
number of patients treated by each care provider.7
Despite these efforts, compliance with the CONSORT checklist has remained poor. It is
possible that endorsement is not optimal because some authors perceive the 25-item checklist as
a barrier to complying with the CONSORT recommendations. This concern led to a retreat of the
CONSORT NPT group in May 2014 in the beautiful Chaˆteau d’Ermmenonville, France, which
included epidemiologists, trialists, statisticians, journal and publisher representatives, and a few
surgeons. The main topic was how to enhance adherence of authors and journals to the CONSORT
NPT guidelines. The group agreed to a 2-step implementation of the guidelines, starting with a first
step requiring the completion of a 10-item CONSORT NPT checklist, called the CONSORT NPT
“submission” checklist, to be provided upon submission of any surgical RCT, followed by the whole
CONSORT NPT checklist6 to be completed after provisional acceptance by the journal; that is, this
information will not influence the decision of whether or not to accept a manuscript for publication.
Making the CONSORT NPT submission checklist mandatory for submission is meant to
guarantee sufficient critical information to enable proper understanding and evaluation of the trial.
We hope that the reduced 10-item checklist will make it easier for authors to comply with the journal’s
implementation of CONSORT NPT. Use of CONSORT is associated with more completely reported
RCTs.8 The group of surgeons and NPT CONSORT group leaders, listed later, selected 10 key
items, all from the CONSORT NPT checklist, which are readily available to any prospective authors.
These items are presented, with examples and short explanations, to facilitate understanding and
implementation by surgeons (see the Supplemental Table and Flow sheet, available at . . . ). The
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whole CONSORT NPT checklist will have to be provided only for
the accepted RCTs and will be published online along with the article
in compliance with the CONSORT NPT checklist.
Annals of Surgery, as one of the leading journals in surgery,
will implement this policy for all submissions beginning January
2015. Thus, the CONSORTNPT submission checklist will have to be
completed online upon submission of any RCT. If the manuscript is
provisionally accepted for publication, the whole CONSORT check-
list will be required at the time the revised manuscript is submitted
but without impact on the decision to publish the manuscript. We
hope that this new policy will enable better reporting of RCTs and
facilitate further interpretation in the setting of other results and even
facilitate meta-analyses.
Similar to RCTs, adherence to reporting guidelines is criti-
cal for interpreting meta-analyses or systematic reviews. Annals of
Surgery strongly encourages prospective authors to complete the
PRISMA (Preferred Reporting Items of Systematic reviews and
Meta-Analyses) checklist when submitting meta-analyses or system-
atic reviews. The PRISMA guideline was proposed in 20099 as an
update of the initial QUOROM (Quality Of Reporting Of Meta-
analyses) checklist, designed to describe meta-analyses.10 PRISMA
is an evidence-basedminimumset of 27 items for reporting systematic
reviews and meta-analyses, which is part of a broader effort to im-
prove the reporting of different types of health research and, in turn, to
improve the quality of research used in decisionmaking in health care.
In summary, we are introducing the CONSORT NPT submis-
sion checklist consisting of 10 items to be completed upon submission
of any RCTs. The items with examples are readily available online
along with the submission process to Annals of Surgery. A flow dia-
gram, prepared by the CONSORT group, is also provided to facilitate
the implementation of this new policy. The whole CONSORT NPT
checklist will be provided after provisional acceptance and before
publication.
SPECIAL NOTE
The CONSORT NPT submission checklist was developed
by the participating surgeons at the NPT CONSORT retreat: Peter
McCulloch, Oxford, UK, Markus, Diener, Heidelberg, Germany,
Ksenija Slankamenac, Zurich, Switzerland, and Pierre A. Clavien,
Zurich, Switzerland, with the input of the chairs of the CONSORT
NPT group, Isabelle Boutron and Philippe Ravaud, and CONSORT
leaders, Doug Altman, Ken Schulz, and David Moher.
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